FDA Warning Letter — BP

Case 536615 — FEI 3013759702

The FDA took a Warning Letter action against BP on Aug 31, 2017 (Dayton, OH). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Aug 31, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Dayton, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.